Showing results (151-160 of 232) with videos related to

Sort By:
Pageof 24
Pharmacoeconomics|March 24, 2020
The Accuracy and Usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability RatingAaron P Mitchell, Pranammya Dey, Jennifer A Ohn, et al.
JNCI Cancer Spectrum|June 2, 2024
Trends in financial payments from industry to US cancer centers, 2014-2021Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, et al.
JAMA Oncology|May 1, 2018
Delays in the Publication of Important Clinical Trial Findings in OncologyLindor Qunaj, Raina H Jain, Coral L Atoria, et al.
Journal of the National Cancer Institute|September 21, 2022
New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast CancerJacob C Cogan, Rohit R Raghunathan, Melissa P Beauchemin, et al.
BMJ (Clinical Research Ed.)|October 25, 2023
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort studyAaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, et al.
Journal of the National Cancer Institute|October 1, 2021
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate CancerAaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
Infection Control and Hospital Epidemiology|August 21, 2002
Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemiaPeter B Bach, Sharp F Malak, Joseph Jurcic, et al.
Journal of Surgical Oncology|May 29, 2003
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resectionDeborah Schrag, Katherine S Panageas, Elyn Riedel, et al.
Pageof 24